<DOC>
	<DOCNO>NCT02044185</DOCNO>
	<brief_summary>Acute Graft-versus-host disease ( aGVDH ) allogeneic hematopoietic stem cell transplantation one meaningful issue aspect patient 's recovery survival . recent year , understand pathology GVHD much important prevent treat aGVHD . additionally , ( oral ) mucositis one problem patient high dose chemotherapy , mucositis high-dose chemotherapy relate HMGB-1 proinflamtory cytokine . HMGB1 nuclear protein act transcription factor , , release outside cell damage cell necrotic tissue , work cytokine promoter inflammation cancer . point , report article correlation HMGB1 aGVHD human . recently , see excessive secretion serum HMGB1 mouse model , base result , check correlation HMGB1 aGVHD/ oral mucositis human .</brief_summary>
	<brief_title>Clinical Implications HMGB1 Patients Treated With Chemotherapy Hematopoietic Stem Cell Transplantation</brief_title>
	<detailed_description>1. material 1 ) inclusion criterion 1. 18-year-old 2. patient myeloablative condition regimen 3. autologous transplant 4. patient confirmation acute GVHD grade II 5. patient salvage chemotherapy 2 ) exclusion criterion 1. old age ( 60-year-old ) 2. patient reduced intensity stem cell transplantation 2. method 1 ) check serum level HMGB1 , TNF-a , IL-1b , IL-6 , Th1 , Th2 , Th17 , FoxP3 7-day transplant day ( D-7 ) , transplant day ( D0 ) , 7-day transplant ( D+7 ) , D+14 , D+21 . 2 ) check immunohistochemistry level tissue diagnose aGVHD ( perform sigmoidoscopy random biopsy gut routine process center ) 3 ) check oral mucositis grade ( use WHO grade system , NCI -CTC ver.3 score system ) 3. analysis 1 ) student t-test , chi-square test 2 ) survival analysis</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>1 . 1. 18yearold 2. patient myeloablative condition regimen 3. autologous transplant 4. patient confirmation acute GVHD grade II 5. patient salvage chemotherapy 2 . 1. old age ( 75yearold ) 2. patient reduced intensity stem cell transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>HMGB1 Protein</keyword>
	<keyword>Graft versus Host Disease</keyword>
	<keyword>Immunosuppressive Agents</keyword>
	<keyword>oral mucositis</keyword>
</DOC>